Who Generates More Revenue? United Therapeutics Corporation or Walgreens Boots Alliance, Inc.

Revenue Battle: Walgreens vs. United Therapeutics

__timestampUnited Therapeutics CorporationWalgreens Boots Alliance, Inc.
Wednesday, January 1, 2014128851900076392000000
Thursday, January 1, 20151465761000103444000000
Friday, January 1, 20161598800000117351000000
Sunday, January 1, 20171725300000118214000000
Monday, January 1, 20181627800000131537000000
Tuesday, January 1, 20191448800000120074000000
Wednesday, January 1, 20201483300000121982000000
Friday, January 1, 20211685500000132509000000
Saturday, January 1, 20221936300000132703000000
Sunday, January 1, 20232327500000139081000000
Monday, January 1, 2024147658000000
Loading chart...

Unlocking the unknown

Revenue Showdown: United Therapeutics vs. Walgreens Boots Alliance

In the ever-evolving landscape of corporate giants, revenue generation is a key indicator of success. Over the past decade, Walgreens Boots Alliance, Inc. has consistently outperformed United Therapeutics Corporation in terms of revenue. From 2014 to 2023, Walgreens' revenue surged by approximately 82%, peaking at $139 billion in 2023. In contrast, United Therapeutics saw a more modest growth of around 81%, reaching $2.3 billion in the same year.

While Walgreens' revenue is significantly higher, United Therapeutics has shown a steady upward trend, reflecting its resilience and growth potential in the pharmaceutical sector. The data for 2024 is incomplete, but Walgreens' trajectory suggests continued dominance. This comparison highlights the diverse strategies and market positions of these two companies, offering insights into their financial health and future prospects.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025